[2S,4S]4-(3,5-bis-trifluoromethyl-benzylamino)-2-cyclopropyl-6-trifluoromethyl-3,4-dihydro-2H-quinoline-1-carboxylic acid ethyl ester | 261947-58-4

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 喹啉及其衍生物
• 英文名称: [2S,4S]4-(3,5-bis-trifluoromethyl-benzylamino)-2-cyclopropyl-6-trifluoromethyl-3,4-dihydro-2H-quinoline-1-carboxylic acid ethyl ester
• 英文别名: ethyl (2S,4S)-4-[[3,5-bis(trifluoromethyl)phenyl]methylamino]-2-cyclopropyl-6-(trifluoromethyl)-3,4-dihydro-2H-quinoline-1-carboxylate
• CAS: 261947-58-4
• 化学式: C₂₅H₂₃F₉N₂O₂
• 分子量: 554.455
• InChiKey: LHWOTJMHKOGGJJ-FPOVZHCZSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  6.5
• 重原子数：
  38
• 可旋转键数：
  6
• 环数：
  4.0
• sp3杂化的碳原子比例：
  0.48
• 拓扑面积：
  41.6
• 氢给体数：
  1
• 氢受体数：
  12

文献信息

• Method of inhibiting remnant lipoprotein production
  申请人：Japan Tobacco, Inc.

  公开号：EP2316447A1

  公开（公告）日：2011-05-04

  The present invention aims at provision of a method for inhibiting remnant lipoprotein production and a remnant lipoprotein production inhibitor, which includes administering a compound having a CETP inhibitory activity to an administration subject. The remnant lipoprotein production inhibitor of the present invention contains a compound having a CETP inhibitory activity as an active ingredient.

  本发明旨在提供一种抑制残余脂蛋白生成的方法和一种残余脂蛋白生成抑制剂，其中包括向给药对象施用一种具有CETP抑制活性的化合物。本发明的残余脂蛋白生成抑制剂含有一种具有 CETP 抑制活性的化合物作为活性成分。
• Method of Inhibiting remnant lipoprotein production
  申请人：Japan Tobacco, Inc.

  公开号：EP2319509A1

  公开（公告）日：2011-05-11

  The present invention aims at provision of a method for inhibiting remnant lipoprotein production and a remnant lipoprotein production inhibitor, which includes administering a compound having a CETP inhibitory activity to an administration subject. The remnant lipoprotein production inhibitor of the present invention contains a compound having a CETP inhibitory activity as an active ingredient.

  本发明旨在提供一种抑制残余脂蛋白生成的方法和一种残余脂蛋白生成抑制剂，其中包括向给药对象施用一种具有CETP抑制活性的化合物。本发明的残余脂蛋白生成抑制剂含有一种具有 CETP 抑制活性的化合物作为活性成分。
• 4-AMINO SUBSTITUTED-2-SUBSTITUTED-1,2,3,4-TETRAHYDROQUINOLINES AS CETP INHIBITORS
  申请人：Pfizer Products Inc.

  公开号：EP1114032A1

  公开（公告）日：2001-07-11
• Method for inhibiting lipid absorption and lipid absorption inhibitor
  申请人：Yonemori Fumihiko

  公开号：US20060270705A1

  公开（公告）日：2006-11-30

  The present invention relates to a method of inhibiting lipid absorption through the small intestine, which comprises administering a compound having a CETP inhibitory activity to an administration subject, and an inhibitor of lipid absorption through the small intestine characterized in that it comprises a compound having a CETP inhibitory activity as an active ingredient. The lipid absorption inhibitor of the present invention can prevent and/or treat diseases such as for example hyperlipidemia, arteriosclerosis, coronary artery diseases, obesity, diabetes, hypertension and metabolic syndrome by inhibiting lipid absorption through the small intestine.
• METHOD OF INHIBITING REMNANT LIPOPROTEIN PRODUCTION
  申请人：Okamoto Hiroshi

  公开号：US20110189210A1

  公开（公告）日：2011-08-04

  The present invention aims at provision of a method for inhibiting remnant lipoprotein production and a remnant lipoprotein production inhibitor, which includes administering a compound having a CETP inhibitory activity to an administration subject. The remnant lipoprotein production inhibitor of the present invention contains a compound having a CETP inhibitory activity as an active ingredient.